Health / Medical Topics

    BRAF (V600E) kinase inhibitor RO5185426

    Pronunciation

    A drug used to treat advanced melanoma that has a mutated (changed) form of a cell protein called BRAF. It is also being studied in the treatment of other types of cancer. BRAF (V600E) kinase inhibitor RO5185426 blocks this mutated protein, which may stop the growth of cancer cells. It is a type of kinase inhibitor and a type of targeted therapy agent. Also called PLX4032, RG7204, vemurafenib, and Zelboraf. (NCI Dictionary)




    YOU MAY ALSO LIKE

    Abnormal decrease of rate of breathing.
    Bradykinin receptor B2 protein (391 aa, 44 kD) is a cell communication process protein that is encoded by the BDKRB2 gene and…
    A nonapeptide kinin and neuropeptide involved in blood pressure regulation and pain receptor stimulation.
    An electrocardiographic finding of abnormally slow heart rate. Thresholds for different age, gender, and patient populations exist.
    Cardiac arrest that was a result of bradycardia.
    An abnormally slow heart rate. Thresholds for different age, gender, and patient populations exist.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact